This federal contract award, with an ID of SPE2DX22D0079|SPE2D825FABB1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $454,977.65 firm-fixed-price delivery order contract has an ultimate completion date of December 10, 2024 and was awarded on December 9, 2024.
The contract provides a range of pharmaceutical products and medical supplies to support military healthcare programs. Key items include specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across various therapeutic areas. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to deliver critical medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions globally. There were no set-aside requirements associated with this particular contract award.
Generated 3/10/25, 9:53 AM